243 related articles for article (PubMed ID: 33205348)
1. Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways.
Hamilton KL; Sheehan SA; Retzbach EP; Timmerman CA; Gianneschi GB; Tempera PJ; Balachandran P; Goldberg GS
J Cancer Res Clin Oncol; 2021 Feb; 147(2):445-457. PubMed ID: 33205348
[TBL] [Abstract][Full Text] [Related]
2. Maackia amurensis seed lectin (MASL) and soluble human podoplanin (shPDPN) sequence analysis and effects on human oral squamous cell carcinoma (OSCC) cell migration and viability.
Yin AC; Holdcraft CJ; Brace EJ; Hellmig TJ; Basu S; Parikh S; Jachimowska K; Kalyoussef E; Roden D; Baredes S; Capitle EM; Suster DI; Shienbaum AJ; Zhao C; Zheng H; Balcaen K; Devos S; Haustraete J; Fatahzadeh M; Goldberg GS
Biochem Biophys Res Commun; 2024 May; 710():149881. PubMed ID: 38583233
[TBL] [Abstract][Full Text] [Related]
3. WNT3 promotes chemoresistance to 5-Fluorouracil in oral squamous cell carcinoma via activating the canonical β-catenin pathway.
Zhang X; Sun K; Gan R; Yan Y; Zhang C; Zheng D; Lu Y
BMC Cancer; 2024 May; 24(1):564. PubMed ID: 38711026
[TBL] [Abstract][Full Text] [Related]
4. Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms.
Ochoa-Alvarez JA; Krishnan H; Pastorino JG; Nevel E; Kephart D; Lee JJ; Retzbach EP; Shen Y; Fatahzadeh M; Baredes S; Kalyoussef E; Honma M; Adelson ME; Kaneko MK; Kato Y; Young MA; Deluca-Rapone L; Shienbaum AJ; Yin K; Jensen LD; Goldberg GS
Oncotarget; 2015 Apr; 6(11):9045-60. PubMed ID: 25826087
[TBL] [Abstract][Full Text] [Related]
5. Plant lectin can target receptors containing sialic acid, exemplified by podoplanin, to inhibit transformed cell growth and migration.
Ochoa-Alvarez JA; Krishnan H; Shen Y; Acharya NK; Han M; McNulty DE; Hasegawa H; Hyodo T; Senga T; Geng JG; Kosciuk M; Shin SS; Goydos JS; Temiakov D; Nagele RG; Goldberg GS
PLoS One; 2012; 7(7):e41845. PubMed ID: 22844530
[TBL] [Abstract][Full Text] [Related]
6. Evidence that Maackia amurensis seed lectin (MASL) exerts pleiotropic actions on oral squamous cells with potential to inhibit SARS-CoV-2 infection and COVID-19 disease progression.
Sheehan SA; Hamilton KL; Retzbach EP; Balachandran P; Krishnan H; Leone P; Lopez-Gonzalez M; Suryavanshi S; Kumar P; Russo R; Goldberg GS
Exp Cell Res; 2021 Jun; 403(1):112594. PubMed ID: 33823179
[TBL] [Abstract][Full Text] [Related]
7. Migration and invasion of oral squamous carcinoma cells is promoted by WNT5A, a regulator of cancer progression.
Prgomet Z; Axelsson L; Lindberg P; Andersson T
J Oral Pathol Med; 2015 Nov; 44(10):776-84. PubMed ID: 25459554
[TBL] [Abstract][Full Text] [Related]
8. Maackia amurensis seed lectin (MASL) ameliorates articular cartilage destruction and increases movement velocity of mice with TNFα induced rheumatoid arthritis.
Hamilton KL; Greenspan AA; Shienbaum AJ; Fischer BD; Bottaro A; Goldberg GS
Biochem Biophys Rep; 2022 Dec; 32():101341. PubMed ID: 36120492
[TBL] [Abstract][Full Text] [Related]
9. Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment.
Hwang BO; Park SY; Cho ES; Zhang X; Lee SK; Ahn HJ; Chun KS; Chung WY; Song NY
Front Immunol; 2021; 12():807600. PubMed ID: 34987523
[TBL] [Abstract][Full Text] [Related]
10. Propranolol inhibits cell viability and expression of the pro-tumorigenic proteins Akt, NF-ĸB, and VEGF in oral squamous cell carcinoma.
Shibuya CM; Tjioe KC; Oliveira SHP; Bernabé DG
Arch Oral Biol; 2022 Apr; 136():105383. PubMed ID: 35240444
[TBL] [Abstract][Full Text] [Related]
11. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1.
Chen L; Zhu Q; Lu L; Liu Y
Bioengineered; 2020 Dec; 11(1):91-102. PubMed ID: 31906769
[TBL] [Abstract][Full Text] [Related]
12. CMTM6 drives cisplatin resistance by regulating Wnt signaling through the ENO-1/AKT/GSK3β axis.
Mohapatra P; Shriwas O; Mohanty S; Ghosh A; Smita S; Kaushik SR; Arya R; Rath R; Das Majumdar SK; Muduly DK; Raghav SK; Nanda RK; Dash R
JCI Insight; 2021 Feb; 6(4):. PubMed ID: 33434185
[TBL] [Abstract][Full Text] [Related]
13. In vitro and in vivo synergistic anti-tumor effect of LIN28 inhibitor and metformin in oral squamous cell carcinoma.
Chen H; Sa G; Li L; He S; Wu T
Eur J Pharmacol; 2021 Jan; 891():173757. PubMed ID: 33249080
[TBL] [Abstract][Full Text] [Related]
14. MSX2 represses tumor stem cell phenotypes within oral squamous cell carcinomas via SOX2 degradation.
Keyimu R; Tuerdi M; Zhao Z
Exp Biol Med (Maywood); 2021 Dec; 246(24):2660-2670. PubMed ID: 34435915
[TBL] [Abstract][Full Text] [Related]
15. Maackia amurensis agglutinin enhances paclitaxel induced cytotoxicity in cultured non-small cell lung cancer cells.
Chhetra Lalli R; Kaur K; Dadsena S; Chakraborti A; Srinivasan R; Ghosh S
Biochimie; 2015 Aug; 115():93-107. PubMed ID: 25978938
[TBL] [Abstract][Full Text] [Related]
16. Epidermal growth factor/epidermal growth factor receptor signaling blockage inhibits tumor cell-derived exosome uptake by oral squamous cell carcinoma through macropinocytosis.
Sasabe E; Tomomura A; Liu H; Sento S; Kitamura N; Yamamoto T
Cancer Sci; 2022 Feb; 113(2):609-621. PubMed ID: 34874595
[TBL] [Abstract][Full Text] [Related]
17. Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma - clinical implications.
Patni AP; Harishankar MK; Joseph JP; Sreeshma B; Jayaraj R; Devi A
Cell Oncol (Dordr); 2021 Jun; 44(3):473-494. PubMed ID: 33704672
[TBL] [Abstract][Full Text] [Related]
18. Dihydroartemisinin represses oral squamous cell carcinoma progression through downregulating mitochondrial calcium uniporter.
Zheng S; Wu R; Deng Y; Zhang Q
Bioengineered; 2022 Jan; 13(1):227-241. PubMed ID: 34847839
[TBL] [Abstract][Full Text] [Related]
19. Heterocellular N-cadherin junctions enable nontransformed cells to inhibit the growth of adjacent transformed cells.
Sheehan SA; Retzbach EP; Shen Y; Krishnan H; Goldberg GS
Cell Commun Signal; 2022 Feb; 20(1):19. PubMed ID: 35177067
[TBL] [Abstract][Full Text] [Related]
20. CCL18-NIR1 promotes oral cancer cell growth and metastasis by activating the JAK2/STAT3 signaling pathway.
Jiang X; Huang Z; Sun X; Zheng X; Liu J; Shen J; Jia B; Luo H; Mai Z; Chen G; Zhao J
BMC Cancer; 2020 Jul; 20(1):632. PubMed ID: 32641093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
